Sandoz Launches Global Biosimilars Initiative
‘Act4Biosimilars’ Aims To Increase Adoption By At Least 30% In 30 Countries By 2030
Sandoz has launched a global campaign to increase uptake of biosimilars, under the banner of Act4Biosimilars. The initiative aims to increase the adoption of biosimilars by at least 30% in at least 30 countries by 2030.
